Guangming Chen
Inventor
Stats
- 36 US patents issued
- 58 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 36 US Patents Issued
- 58 US Applications Filed
- 447 Total Citation Count
- Nov 13, 2023 Most Recent Filing
- Apr 8, 2004 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
F. HOFFMANN-LA ROCHE AG | 2
| 2012
|
MIDCAP FINANCIAL TRUST, AS AGENT | 1
1 | 2008
2015 |
Shanghai Institutes for Biological Sciences, CAS | 1
| 2011
|
PCT Therapeutics, Inc. | 2
2 | 2005
2007 |
PTC THERAPEUTICS, INC. | 2
14 6 8 1 1 15 4 9 4 2 4 1 1 | 2004
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 |
SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES | 2
| 2011
|
THERAPEUTICS, INC. | 1
| 2007
|
SCHERING CORPORATION | 4
| 2010
|
ZHEJIANG LANTIAN ENVIRONMENTAL PROTECTION HI-TECH CO., LTD. | 1
2 | 2004
2005 |
Inventor Addresses
Address | Duration |
---|---|
Bridgewater, NJ | Jul 28, 05 - Nov 06, 08 |
Bridgewater, NJ, US | Oct 14, 04 - Nov 12, 24 |
Changsha, CN | Feb 24, 22 - Feb 24, 22 |
Hangzhou City, CN | Jan 05, 06 - Apr 12, 07 |
Hangzhou, CN | Dec 02, 08 - Dec 02, 08 |
Shanghai, CN | May 02, 13 - Feb 27, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 3 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 41 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 20 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0064,957 | 2025 | EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF | 0 |
12139499 | 2024 | Heteroaryl compounds for treating Huntington's disease | 0 |
2024/0346,341 | 2024 | METHOD AND APPARATUS FOR FUSING LAYERS OF DIFFERENT MODELS | 0 |
2024/0336,613 | 2024 | HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | 0 |
11999748 | 2024 | Exatecan derivatives, linker-payloads, and conjugates and thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.